معرفی
Drishya Kurup serves as a Research Instructor in the Department of Microbiology & Immunology at the College of Life Sciences, Thomas Jefferson University. Her work focuses on developing vaccines against emergent infectious diseases using viral vector platforms including Measles, Rabies, and VSV vaccine strains.
Her research spans Vaccine Development, Viral Vector Vaccines, Infectious Diseases, Emerging Infectious Diseases, Immunology, and Virology. She investigates how viral vectors can be engineered to target pathogens like SARS-CoV-2, Influenza A H5, Lassa fever, Lyssavirus, and Ebola virus, with emphasis on immunogenicity, safety profiles, and cross-protection mechanisms.
Analysis of her publications reveals a consistent focus on rabies-vectored vaccine platforms across multiple high-threat pathogens. Her work demonstrates translational applications in animal models including cattle and nonhuman primates, with particular attention to adjuvant effects, neuropathology modulation, and protection against lethal challenges. Current research trends emphasize platform versatility for rapid response to emerging outbreaks.
